Cargando…
An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
BACKGROUND: Vaccination is considered as the most effective preventive method to control influenza. The hallmark of influenza virus is the remarkable variability of its major surface glycoproteins, HA and NA, which allows the virus to evade existing anti-influenza immunity in the target population....
Autores principales: | Ma, Ji-Hong, Yang, Fu-Ru, Yu, Hai, Zhou, Yan-Jun, Li, Guo-Xin, Huang, Meng, Wen, Feng, Tong, Guangzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716895/ https://www.ncbi.nlm.nih.gov/pubmed/23834899 http://dx.doi.org/10.1186/1743-422X-10-227 |
Ejemplares similares
-
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
por: Zhao, Guangyu, et al.
Publicado: (2010) -
An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses
por: Xiong, Feifei, et al.
Publicado: (2023) -
Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
por: Laddy, Dominick J., et al.
Publicado: (2008) -
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018) -
Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
por: Baz, Mariana, et al.
Publicado: (2015)